-
LCTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Lineage Cell Therapeutics (LCTX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 28.31 mm | 28.31 mm | 28.31 mm | 28.31 mm | 28.31 mm | 28.31 mm |
Cash burn (monthly) | 621.33 k | 307.83 k | 1.28 mm | 1.89 mm | 1.93 mm | 1.90 mm |
Cash used (since last report) | 2.69 mm | 1.33 mm | 5.53 mm | 8.19 mm | 8.34 mm | 8.20 mm |
Cash remaining | 25.62 mm | 26.98 mm | 22.77 mm | 20.12 mm | 19.97 mm | 20.11 mm |
Runway (months of cash) | 41.2 | 87.6 | 17.8 | 10.6 | 10.4 | 10.6 |
13F holders | Current |
---|---|
Total holders | 114 |
Opened positions | 9 |
Closed positions | 9 |
Increased positions | 28 |
Reduced positions | 24 |
13F shares | Current |
---|---|
Total value | 83.62 bn |
Total shares | 134.55 mm |
Total puts | 1.00 k |
Total calls | 63.80 k |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
Broadwood Partners | 41.67 mm | $46.25 mm |
Broadwood Capital | 41.67 mm | $37.72 bn |
BlackRock | 9.92 mm | $8.98 bn |
Vanguard | 8.60 mm | $7.78 bn |
Defender Capital | 5.00 mm | $4.53 bn |
Logos Global Management | 5.00 mm | $4.53 bn |
Raffles Associates | 4.51 mm | $4.08 bn |
Geode Capital Management | 3.68 mm | $3.33 bn |
STT State Street | 2.61 mm | $2.36 bn |
BAC Bank of America | 1.37 mm | $1.24 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Jan 25 | Broadwood Partners | Common Shares | Buy | Acquire P | Yes | No | 0 | 0 | 0.00 | 49,560,992 |
27 Jan 25 | Broadwood Partners | Common Shares | Buy | Acquire P | No | No | 0.76 | 7,894,737 | 6.00 mm | 49,560,992 |
27 Jan 25 | Broadwood Partners | Common Warrant Common Shares | Buy | Acquire P | Yes | No | 0.91 | 0 | 0.00 | 7,894,737 |
27 Jan 25 | Broadwood Partners | Common Warrant Common Shares | Buy | Acquire P | No | No | 0.91 | 7,894,737 | 7.18 mm | 7,894,737 |
26 Nov 24 | George A. Samuel III | Common Shares | Buy | Acquire P | No | No | 0.6 | 15,000 | 9.00 k | 22,184 |
26 Nov 24 | Jill Ann Howe | Common Shares | Buy | Acquire P | No | No | 0.59 | 15,000 | 8.85 k | 25,500 |
22 Nov 24 | Mulroy Michael H. | Common Shares | Buy | Acquire P | No | No | 0.566 | 40,000 | 22.64 k | 298,555 |
21 Nov 24 | Culley Brian M | Common Shares | Buy | Acquire P | No | No | 0.6 | 40,000 | 24.00 k | 194,842 |